In fact, according to a recent survey, over one-quarter (26%) of consumers in the United States plan to take a weight loss drug to achieve their 2025 New Year's resolution goals. This trend and ...

Weight loss medications like Ozempic and Wegovy have become increasingly popular over the last few years. For people struggling to lose weight through diet and exercise alone, these medications ...

Opens in a new tab or window Just over half of patients with overweight or obesity discontinued their GLP-1 receptor agonist within 1 year ... every 1% of body weight loss was tied to a 3% ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data.

Daniel Liberto is a journalist with over 10 years of experience working with ... picture alliance / Getty Images Weight-loss drugs are transforming both health care and Wall Street, with leading ...

Despite the study being short, and people taking the drugs for only 3.5 years because of how ... surprising finding" was the increase in joint pain, since weight loss should reduce pressure ...

The newest weight-loss drugs ... whom were taking the GLP-1 medications and some who took other diabetes treatments. They tracked health outcomes over about four years for 175 different conditions ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

Starting in 2022, Haley Sipes lost 75 pounds over ... year-old mother of three chronicled her weight loss journey, commenters speculated that she was using Ozempic or another weight loss drug.

Novo Nordisk has sued the government over the ... based drugs stimulate the GLP-1 hormone.) The Biden administration last year proposed expanding coverage of weight-loss drugs for millions on ...